
Kubona uburyo bwiza bwo kuvura kanseri y'ibihaha birashobora kuba byinshi. Iki gitabo cyuzuye kiragufasha kumva amahitamo yawe no kumenya ubuvuzi bwihariye hafi yawe. Tuzasesengura uburyo butandukanye bwo kuvura bujyanye n’imihindagurikire y’imiterere yihariye, dusobanure akamaro k’ubuvuzi bwihariye, tunatanga ibikoresho byo gushakisha abahanga mu bumenyi bwa oncologue n’ibigo by’ubushakashatsi mu karere kanyu.
Kanseri y'ibihaha ni indwara igoye, kandi kuba hari ihinduka ry’imiterere ihindagurika bigira ingaruka zikomeye ku ngamba zo kuvura. Ihinduka ry’imihindagurikire rigira ingaruka ku ngirabuzimafatizo za kanseri zikura kandi zigasubiza imiti. Kumenya ihinduka ryihariye ritera kanseri yibihaha ningirakamaro mugutegura imiti yihariye. Guhinduka bisanzwe birimo EGFR, ALK, ROS1, BRAF, nabandi. Uburyo bwo kuvura buratandukanye cyane bitewe na mutation yamenyekanye. Kurugero, abarwayi bafite ihinduka rya EGFR barashobora kungukirwa nubuvuzi bugamije nka tyrosine kinase inhibitor (TKIs).
Kwipimisha genetike ni ngombwa kugirango umenye ihinduka ry’imiterere yihariye igaragara mu ngirabuzimafatizo za kanseri y'ibihaha. Ibi mubisanzwe birimo biopsy, aho hasesenguwe urugero ruto rw'ibibyimba. Uburyo butandukanye burahari, harimo ibisekuruza bizakurikiraho (NGS), bishobora kumenya intera ihindagurika icyarimwe. Oncologue wawe azakuyobora muburyo bukwiye bwo kwipimisha no gusobanura ibisubizo.
Umuti wa kanseri y'ibihaha akenshi birimo guhuza imiti ijyanye na mutation yihariye. Ibi bishobora kubamo:
Ubuvuzi bugamije kwibasira poroteyine zidasanzwe zikorwa na selile ya kanseri kubera ihinduka ry’imiterere. Iyi miti akenshi ikora neza kandi ifite ingaruka nke ugereranije na chimiotherapie gakondo. Ingero zirimo TKI nka afatinib, gefitinib, na erlotinib kuri mutation ya EGFR, na crizotinib cyangwa alectinib kuri ALK ihinduka. Oncologue wawe azagufasha gusobanukirwa nubuvuzi bugenewe bukwiranye na mutation yawe yihariye.
Immunotherapy ikoresha imbaraga z'umubiri wawe kugirango irwanye kanseri. Ubu buryo bwo kuvura burashobora kuba ingirakamaro muburyo bumwe na bumwe bwa kanseri y'ibihaha. Inhibitori ya Checkpoint, nka pembrolizumab na nivolumab, bakunze gukoresha imiti ikingira indwara.
Mugihe imiti igamije kuvura no gukingira indwara ikundwa cyane na mutation genetique, chimiotherapie ikomeza kuba amahitamo yingirakamaro, cyane cyane hamwe nubundi buryo bwo kuvura cyangwa kurwanya indwara zateye imbere. Oncologue wawe azagena uburyo bukwiye bwa chimiotherapie ukurikije ibihe byihariye.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango yice selile. Bikunze gukoreshwa hamwe nubundi buvuzi cyangwa kugabanya ibimenyetso mubyiciro byateye imbere.
Kubona inararibonye oncologiste hamwe nibigo byita kubuvuzi kanseri y'ibihaha ni ngombwa. Tangira ubaza umuganga wawe wibanze, ushobora kukwohereza kuri oncologue. Urashobora kandi gushakisha kumurongo kubantu ba oncologiste hamwe na kanseri hafi yawe. Ibitaro byinshi n’ibigo by’ubushakashatsi byeguriye gahunda ya kanseri y'ibihaha ifite ubuhanga mu gupima ingirabuzima fatizo no kuvura umuntu ku giti cye. Tekereza kugenzura aho uhurira n’imiryango ikora ubushakashatsi bwa kanseri nka National Institute Institute (NCI). Uwiteka Shandong Baofa Ikigo Cyubushakashatsi Kanseri ni ikigo kiyobora gitanga ubuvuzi buhanitse nubushakashatsi muri oncology.
Amakuru yatanzwe hano ni kubumenyi rusange nintego zamakuru gusa, kandi ntabwo bigize inama zubuvuzi. Buri gihe ujye ubaza umuganga wawe cyangwa abandi bashinzwe ubuzima babishoboye bafite ibibazo ushobora kuba ufite bijyanye nuburwayi. Ntuzigere wirengagiza inama zubuvuzi zabigize umwuga cyangwa gutinda kubishakisha kubera ikintu wasomye kururu rubuga.
| Ubwoko bwa Mutation | Amahitamo yo kuvura |
|---|---|
| EGFR | Afatinib, Gefitinib, Erlotinib, Osimertinib |
| ALK | Crizotinib, Alectinib, Brigatinib |
| ROS1 | Crizotinib, Lorlatinib, Entrectinib |
Inshingano: Aya makuru agenewe intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara iyo ari yo yose.
Inkomoko: [Shyiramo amahuza kumasoko yizewe nka NCI, ingingo zamakuru zamakuru, nibindi, hamwe na rel = nofollow]